Serial 79126616
Live / Registered — Registered — Section 71 accepted (as of 11 May 2024)
What this means for you
Registered since 24 Sept 2013. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79126616
- Registration number
- 4405299
- Mark type
- Design / logo
- Filed
- 15 Jan 2013
- Published for opposition
- 09 Jul 2013
- Registered
- 24 Sept 2013
- Attorney of record
- Christopher Bolinger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of cancer
Owner
- Astellas Pharma Inc., Tokyo, JP
- Astellas Pharma Inc., Tokyo 103-8411, JP
- Astellas Pharma Inc., JP
Prosecution history
- 14 Apr 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 14 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Apr 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 14 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 May 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 11 May 2024 — REGISTERED-SEC.71 ACCEPTED
- 07 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Sept 2023 — TEAS SECTION 71 RECEIVED
- 24 Feb 2023 — INTERNATIONAL REGISTRATION RENEWED
- 24 Sept 2022 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 25 Jun 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Oct 2020 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE